It may be postulated that the increased EMV release observed in cancers is partly driven by elevated PAD expression in cancers and that PAD enzymes—which are amongst the cargo packaged in EMVs—are carried into plasma where they can deiminate target proteins [92]; and aid in the spread of cancer indirectly. The gene discussed is PADI4; the disease is cancer.